Review articleSevere myoclonic epilepsy in infants – a review based on the Tokyo Women's Medical University series of 84 cases
Introduction
Severe myoclonic epilepsy in infants (SME) is one of the most malignant epileptic syndromes and was first described and characterized by Dravet et al. [1], [2]. Since then, SME has been gradually recognized as an independent epileptic syndrome with many characteristic features. SME has been studied intensively not only in Europe but also in Japan [3], [4], [5], [6], [7], [8], [9]. However, diagnosis of SME in the early stage of clinical course inevitably remains equivocal because of the current diagnostic criteria, which places more importance on the characteristic clinical course rather than the specific seizure or electroencephalographic (EEG) manifestations. The term ‘SME’ may wrongly suggest that it is the severest form of myoclonic epilepsy or epilepsy with intractable myoclonic seizures. However, the myoclonic seizures of SME are usually only seen between 1 and 4 years of age and may not be the predominant seizure type [10]. Patients with SME characteristically have multiple seizure types including generalized or unilateral clonic convulsions, alternating hemiconvulsions, and simple or complex partial seizures (CPS), which manifest more often than the myoclonic seizures throughout the clinical course. Accordingly, the term of ‘polymorphous epilepsy’ was once proposed instead of SME [11]. Furthermore, in Japan, several investigators became aware of the existence of a distinct group of patients who closely resemble SME clinically by sharing most of characteristic features of SME in common, but who do not fulfill an essential item of diagnostic criteria for typical SME, that is, myoclonic seizures, so that other designations such as SME borderland or the peripheral type of SME had tentatively been offered [4], [11], [12], [13], [14]. The causal relationship between hot water bathing and the precipitation of seizures has provoked a keen interest among Japanese investigators also [3], [4], [15], [16]. In this article, the authors will present an overview of Japanese research works ever made on SME and related conditions, including a summary of serial studies of the authors' own.
Section snippets
Diagnostic criteria
The International Classification of Epilepsies and Epileptic Syndromes [17] employs the following six clinical and EEG characteristics for assisting a diagnosis of SME: (1) a high incidence of family history of epilepsy or febrile convulsions (FC); (2) normal development before onset; (3) seizures beginning during the first year of life in the form of generalized or unilateral febrile and afebrile clonic seizures, secondary appearance of myoclonic jerks, and often partial seizures; (4) EEGs in
Subjects
The authors recruited 39 patients with SME and 45 with SMEB who were followed-up for at least 1 year and who were more than 4 years old, including the 22 reported in 1987 by Sugama et al. and other cases previously described [19], [25], [26]. The authors adhered to the international classification system [27] to diagnose the seizure type as accurately as possible, and as a consequence, myoclonus and massive myoclonia were distinguished from myoclonic seizures. Massive myoclonia was observed
Seizures susceptible to fever and Japanese style hot water immersion
All patients in our series experienced frequent seizures triggered by fever and by Japanese style hot water immersion. Convulsive seizures during such episodes tended to become prolonged or even status convulsivus. In the SME and SMEB patients, the epileptic seizures were always provoked whenever fever went up over 38°C, despite an AED medication. Thus, the authors paid special attention to the precipitation of seizures due to fever and hot water immersion [16]. It was unclear, however, which
Therapy
The responses of SME patients to AEDs for seizure control has been disappointing [6], [8], [10], [37]. Okada et al. [37] retrospectively studied the efficacy of various treatments in the present 27 children with SME. Among them, the medium-chain triglyceride (MCT) ketogenic diet treatment was most effective, bringing an excellent reduction in both intensity and frequency in all seizure types in four out of ten patients (40%) while the diet was maintained. The efficacy of adinocorticotropic
Prognosis
The intellectual and seizure outcome for SME patients is generally poor [10]. The mortality is high due to status convulsivus, and sometimes due to other sudden unexpected reasons [44]. In the Dravet series, ten out of 63 or 15.9% of SME patients died. In the present study, 12 out of 85 children with SME (n=7) and SMEB (n=5) died at a mean age of 65±23 months (Fig. 9). Seven patients died of status convulsivus, and three died unexpectedly from unknown causes. In addition, one patient died of
Etiology and nosological situation
The 84 patients with SME and SMEB did not show any pre- or perinatal abnormality except for premature delivery or small for date baby (SFD) in a few children. In addition, the authors could not identify any abnormality from laboratory examinations of amino acids, organic acids, lactic acid, or muscle biopsies from one patient. In a neuroimaging study including magnetic resonance imaging (MRI), we did not identify any specific abnormality. However, incidence of the family history of convulsive
Acknowledgements
This research was carried out on the basis of data accumulated from patients, who were intensively studied physically, neurologically, and electro-encephalographically with great difficulty by many medical staff in the pediatric department of Tokyo Women's Medical University from 1968. We thank all the medical staff for their devoted effort.
References (51)
- et al.
Severe myoclonic epilepsy in infancy: evolution of seizures
Seizure
(1997) - et al.
Early diagnosis of severe myoclonic epilepsy in infancy
Brain Dev
(1992) Medically intractable generalized tonic–clonic or clonic seizures in infancy
Epilepsy
(1992)- et al.
Bromides were effective in intractable epilepsy with generalized tonic clonic seizures and onset in early childhood
Brain Dev
(1988) - et al.
Bromide treatment of pharmaco-resistant epilepsies with generalized tonic–clonic seizures
Brain Dev
(1992) - et al.
Clinical study of epilepsy with severe febrile seizures and seizures induced by hot water bath
Brain Dev
(1997) Les epilepsies graves de l'enfant
Vie Med
(1978)- et al.
Myoclonic epilepsies in childhood
Severe myoclonic epilepsy in infancy – a clinical and electroencephalographic study (in Japanese)
Tenkan Kenkyu (J Jpn Epil Soc) (Tokyo)
(1986)- et al.
Clinical and electroencephalographic study of severe myoclonic epilepsy in infancy (Dravet)
Jpn J Psychiatr Neurol
(1987)
Long-term follow-up of severe myoclonic epilepsy in infancy
Severe myoclonic epilepsy in infancy: a long-term follow-up study
Jpn J Psychiatr Neurol
Severe myoclonic epilepsy in infancy: a longitudinal study (in Japanese)
Tenkan Kenkyu (J Jpn Epil Soc) (Tokyo)
Severe myoclonic epilepsy in infants
An investigation on the borderland of severe myoclonic epilepsy in infancy
Jpn J Psychiatr Neurol
A group of childhood epilepsy accompanied by refractory grand mal
Folia Psychiatr Neurol Jpn
The epileptic syndrome sharing common characteristics during early childhood with severe myoclonic epilepsy in infancy
Jpn J Psychiatr Neurol
Long-term course of childhood epilepsy with intractable grand mal seizures
Jpn J Psychiatr Neurol
Clinicoelectroencephalographic concordance between monozygotic twins with severe myoclonic epilepsy in infancy
Epilepsia
Study of the mechanism of seizures induced by hot bathing – ictal EEG of hot bathing induced seizures in severe myoclonic epilepsy in infancy (SMEI) (in Japanese)
1990 Annu Rep Jpn Epilepsy Res Found (Osaka)
Proposal for revised classification of epilepsies and epileptic syndromes
Epilepsia
Treatment of severe myoclonic epilepsy in infants with bromide and its borderline variant
Epilepsia
Diagnosis in severe myoclonic epilepsy in childhood: study of 13 cases
Rev Neurol
Intractable grand mal epilepsy developed in the first year of life
Cited by (144)
Genetics and gene therapy in Dravet syndrome
2022, Epilepsy and BehaviorThe clinical, economic, and humanistic burden of Dravet syndrome – A systematic literature review
2022, Epilepsy and BehaviorMotor and behavioral phenotype of Dravet syndrome in adulthood
2022, Epilepsy and Behavior